2026 recognition underscores the strength of BD’s innovation engine and its contributions to sustainable growth, margin expansion and competitive advantage FRANKLIN LAKES, N.J. (March 6, 2026)...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation...
In today's rapidly evolving health care landscape, nurses are not only caregivers – they are innovators, leaders and catalysts for change. At BD, we recognize the pivotal role nurses play in...
At BD, collaboration isn’t just a value—it’s how we deliver on our Purpose of advancing the world of health™. By bringing together diverse perspectives, we unlock innovation that improves...
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
